Bruce Colwell

1.6k total citations
17 papers, 180 citations indexed

About

Bruce Colwell is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Bruce Colwell has authored 17 papers receiving a total of 180 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Bruce Colwell's work include Colorectal Cancer Treatments and Studies (8 papers), Genetic factors in colorectal cancer (4 papers) and Cancer Treatment and Pharmacology (3 papers). Bruce Colwell is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Genetic factors in colorectal cancer (4 papers) and Cancer Treatment and Pharmacology (3 papers). Bruce Colwell collaborates with scholars based in Canada, United States and Australia. Bruce Colwell's co-authors include Derek J. Jonker, Dongsheng Tu, Christopher J. O’Callaghan, Christopher M. Booth, Niall C. Tebbutt, Jeremy Shapiro, Liting Zhu, Ralph Wong, Malcolm J. Moore and Arjun Gupta and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Bruce Colwell

16 papers receiving 179 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce Colwell Canada 8 145 37 34 31 21 17 180
Ondřej Májek Czechia 4 167 1.2× 57 1.5× 83 2.4× 12 0.4× 36 1.7× 16 223
Alessandro Pastorino Italy 7 129 0.9× 32 0.9× 39 1.1× 17 0.5× 45 2.1× 26 172
Dominique Auby France 6 171 1.2× 61 1.6× 38 1.1× 10 0.3× 31 1.5× 11 207
Sylvie Kirscher France 6 103 0.7× 74 2.0× 18 0.5× 10 0.3× 12 0.6× 13 168
Stefania Eufemia Lutrino Italy 8 136 0.9× 67 1.8× 33 1.0× 8 0.3× 45 2.1× 18 192
Lionel Uwer France 6 140 1.0× 56 1.5× 8 0.2× 21 0.7× 29 1.4× 14 189
Daniele Pignataro Italy 8 104 0.7× 121 3.3× 19 0.6× 22 0.7× 28 1.3× 18 232
Aude Bardot France 8 140 1.0× 49 1.3× 16 0.5× 24 0.8× 37 1.8× 17 253
Federico Augusto Sanchez United States 7 69 0.5× 28 0.8× 22 0.6× 6 0.2× 18 0.9× 15 127
Merete Krogh Denmark 6 195 1.3× 70 1.9× 43 1.3× 13 0.4× 27 1.3× 17 233

Countries citing papers authored by Bruce Colwell

Since Specialization
Citations

This map shows the geographic impact of Bruce Colwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Colwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Colwell more than expected).

Fields of papers citing papers by Bruce Colwell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Colwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Colwell. The network helps show where Bruce Colwell may publish in the future.

Co-authorship network of co-authors of Bruce Colwell

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Colwell. A scholar is included among the top collaborators of Bruce Colwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Colwell. Bruce Colwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Colwell, Bruce, et al.. (2024). The Role of Denosumab Treatment in Recurrent Giant Cell Bone Tumor of the Orbit. Ophthalmic Plastic and Reconstructive Surgery. 40(5). e161–e164. 1 indexed citations
2.
Gupta, Arjun, Christopher J. O’Callaghan, Liting Zhu, et al.. (2024). The association of health-care contact days with physical function and survival in CCTG/AGITG CO.17. JNCI Journal of the National Cancer Institute. 116(8). 1313–1318. 7 indexed citations
3.
Starling, Naureen, Bruce Colwell, John H. Strickler, et al.. (2024). AZUR-2, a phase III, open-label, randomized study of perioperative dostarlimab monotherapy vs standard of care in previously untreated patients with T4N0 or stage III dMMR/MSI-H resectable colon cancer.. Journal of Clinical Oncology. 42(3_suppl). TPS240–TPS240. 3 indexed citations
4.
Gupta, Arjun, Christopher J. O’Callaghan, Liting Zhu, et al.. (2023). Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 Trial. JCO Oncology Practice. 19(6). e859–e866. 42 indexed citations
5.
Loree, Jonathan M., Derek J. Jonker, Hagen F. Kennecke, et al.. (2023). Plasma phosphocreatine (PC) as a predictive biomarker for immune checkpoint inhibition in patients with refractory metastatic colorectal cancer (mCRC): Analysis of the CCTG CO.26 trial.. Journal of Clinical Oncology. 41(4_suppl). 183–183. 1 indexed citations
6.
Rasmussen, Sean A., Ashley Stueck, Bruce Colwell, Daniel Gaston, & Michael J. Carter. (2022). Gastrointestinal stromal tumors caused by novel germline variants in SDHB and KIT: a report of two cases and literature review. Clinical Journal of Gastroenterology. 15(5). 869–875.
7.
Chen, Eric Xueyu, Jonathan M. Loree, Dongsheng Tu, et al.. (2022). Effects of liver metastases on efficacy of immune checkpoint blockade in treatment refractory, metastatic colorectal cancer (CRC): CCTG CO.26.. Journal of Clinical Oncology. 40(16_suppl). 3600–3600. 1 indexed citations
8.
Gill, Sharlene, et al.. (2020). Abstract PO-016: Evaluating the impact of COVID-19 on medical oncology workforce and cancer care in Canada: A serial survey study. Clinical Cancer Research. 26(18_Supplement). PO–16. 1 indexed citations
9.
Chen, Eric Xueyu, Derek J. Jonker, Hagen F. Kennecke, et al.. (2019). CCTG CO.26 trial: A phase II randomized study of durvalumab (D) plus tremelimumab (T) and best supportive care (BSC) versus BSC alone in patients (pts) with advanced refractory colorectal carcinoma (rCRC).. Journal of Clinical Oncology. 37(4_suppl). 481–481. 37 indexed citations
10.
11.
Karachiwala, Hatim & Bruce Colwell. (2015). Imatinib Induced Tumor Lysis Syndrome in a Patient with Gastrointestinal Stromal Tumor. 1 indexed citations
12.
Gill, Sharlene, Scot Dowden, Bruce Colwell, Loretta L. Collins, & Scott Berry. (2014). Navigating later lines of treatment for advanced colorectal cancer – Optimizing targeted biological therapies to improve outcomes. Cancer Treatment Reviews. 40(10). 1171–1181. 13 indexed citations
13.
14.
Rivera, Edgardo, Linda Sutton, Bruce Colwell, et al.. (2002). Multicenter Phase II Study of a 28-Day Regimen of Orally Administered Eniluracil and Fluorouracil in the Treatment of Patients With Anthracycline- and Taxane-Resistant Advanced Breast Cancer. Journal of Clinical Oncology. 20(4). 987–993. 14 indexed citations
15.
16.
Reaume, Neil, et al.. (2000). Rising incidence in hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) in atlantic Canada over a 25-year period. Gastroenterology. 118(4). A1437–A1437. 1 indexed citations
17.
Colwell, Bruce, et al.. (1968). Visualization of the gall bladder and the biliary tract in the absence of a sphincter of Oddi.. PubMed. 19(3). 140–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ondřej Májek Breakdown of academic impact, for papers by Alessandro Pastorino Breakdown of academic impact, for papers by Dominique Auby Breakdown of academic impact, for papers by Sylvie Kirscher Breakdown of academic impact, for papers by Stefania Eufemia Lutrino Breakdown of academic impact, for papers by Lionel Uwer Breakdown of academic impact, for papers by Daniele Pignataro Breakdown of academic impact, for papers by Aude Bardot Breakdown of academic impact, for papers by Federico Augusto Sanchez Breakdown of academic impact, for papers by Merete Krogh
Rankless by CCL
2026